Neogenomics NEO Income Statement (2010-2026)

NASDAQ NEO
$18.63 +1.25 (+7.23%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Neogenomics Quarterly Income Statement

Periods 65 quarters
Latest Jun 2026

Neogenomics reported revenue of $201.66M and net income of $2.24M for the quarter ended Jun 2026, up 11.2% year over year. This income statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
121.34M125.73M117.17M125.07M128.78M138.71M137.22M146.92M151.95M155.55M156.24M164.50M167.82M172.00M168.03M181.33M187.80M190.17M186.67M201.66M
Cost of RevenueCost of Rev
74.10M80.47M78.94M81.13M79.89M81.88M82.41M87.03M89.64M87.96M90.77M92.01M92.94M94.74M94.79M104.07M107.35M106.83M105.81M109.78M
Gross Profit
47.24M45.26M38.23M43.95M48.89M56.83M54.81M59.89M62.31M67.59M65.47M72.49M74.88M77.26M73.25M77.26M80.45M83.34M80.86M91.88M
Operating items
Research & DevelopmentR&D
15.70M15.92M16.30M17.07M16.81M17.14M16.26M18.90M17.61M18.07M20.22M21.68M20.41M22.34M22.68M24.07M21.81M23.44M23.83M27.27M
Selling, General & AdministrativeSG&A
63.84M62.39M66.25M57.95M64.28M54.88M61.55M60.31M61.49M59.76M65.80M63.33M66.97M63.64M68.21M71.75M69.87M63.51M65.74M63.61M
Restructuring CostsRestructuring
4.52M4.68M3.07M2.12M1.21M2.40M1.54M1.01M1.71M
Other Operating ExpensesOther Opex
7.41M8.51M7.71M8.63M7.31M6.67M7.39M7.50M5.29M7.13M7.62M7.89M7.68M7.97M10.18M29.06M15.78M9.80M9.53M10.76M
Operating ExpensesOpex
86.95M86.82M90.26M83.65M88.40M83.21M89.89M89.78M86.51M86.16M96.04M94.44M96.08M95.66M101.07M124.89M107.46M96.76M99.11M101.65M
Operating IncomeOp. Inc
-39.71M-41.57M-52.03M-39.70M-39.51M-26.38M-35.07M-29.89M-24.20M-18.57M-30.57M-21.94M-21.20M-18.40M-27.82M-47.63M-27.01M-13.41M-18.24M-9.77M
EBIT
-39.71M-41.57M-52.03M-39.70M-39.51M-26.38M-35.07M-29.89M-24.20M-18.57M-30.57M-21.94M-21.20M-18.40M-27.82M-47.63M-27.01M-13.41M-18.24M-9.77M
Non-operating items
Non Operating Interest Expenses
1.30M4.84M1.30M0.93M0.14M5.21M1.76M1.78M1.69M1.68M1.69M1.67M1.64M1.62M1.62M0.93M0.60M0.60M0.60M0.78M
Non Operating Investment IncomeNon-Op. Investment Inc.
17.75M
Interest & Investment IncomeInt & Inv Inc
-2.37M-1.05M1.06M0.26M4.53M4.84M0.34M0.31M4.67M4.33M0.15M2.26M1.56M1.52M1.27M1.21M
Other Non Operating IncomeOther Non Op Inc.
0.09M-0.93M0.17M-0.41M0.03M-0.00M-0.11M0.73M-0.10M0.12M-0.26M-0.00M0.32M-0.43M0.07M0.48M-0.34M0.08M-0.01M11.18M
Non Operating IncomeNon Op. Inc.
Net income details
EBT
-23.17M-44.20M-53.16M-41.03M-39.62M-25.52M-33.72M-26.64M-21.45M-15.29M-27.68M-19.02M-17.85M-16.13M-25.66M-45.82M-26.39M-12.41M-17.58M1.83M
Tax ProvisionsTaxes
-2.82M-2.44M-3.75M-5.73M-2.77M-2.84M-2.92M-2.31M-2.94M-0.96M-0.62M-0.38M-0.15M-0.80M0.27M-0.72M0.74M-2.52M-0.47M-0.41M
Profit After TaxPAT
-20.35M-41.76M-49.41M-35.30M-36.85M-22.69M-30.80M-24.33M-18.52M-14.33M-27.06M-18.64M-17.70M-15.32M-25.92M-45.09M-27.13M-9.88M-17.11M2.24M
Income from Continuing OperationsIncome (Continuing)
-20.35M-41.76M-49.41M-35.30M-36.85M-22.69M-30.80M-24.33M-18.52M-14.33M-27.06M-18.64M-17.70M-15.32M-25.92M-45.09M-27.13M-9.88M-17.11M2.24M
Consolidated Net IncomeConsol Net Inc.
-20.35M-41.76M-49.41M-35.30M-36.85M-22.69M-30.80M-24.33M-18.52M-14.33M-27.06M-18.64M-17.70M-15.32M-25.92M-45.09M-27.13M-9.88M-17.11M2.24M
Income towards Parent CompanyParent Net Inc
-20.35M-41.76M-49.41M-35.30M-36.85M-22.69M-30.80M-24.33M-18.52M-14.33M-27.06M-18.64M-17.70M-15.32M-25.92M-45.09M-27.13M-9.88M-17.11M2.24M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-20.35M-41.76M-49.41M-35.30M-36.85M-22.69M-30.80M-24.33M-18.52M-14.33M-27.06M-18.64M-17.70M-15.32M-25.92M-45.09M-27.13M-9.88M-17.11M2.24M
Additional items
EPS (Basic)
-0.17-0.35-0.40-0.28-0.30-0.18-0.25-0.19-0.15-0.11-0.21-0.15-0.14-0.12-0.20-0.35-0.21-0.08-0.130.02
EPS (Diluted)
-0.17-0.35-0.40-0.28-0.30-0.18-0.25-0.19-0.15-0.11-0.21-0.15-0.14-0.12-0.20-0.35-0.21-0.08-0.130.02
Shares Outstanding
122.56M119.96M123.63M124.07M124.42M124.22M125.03M125.36M125.69M125.50M126.11M126.41M126.95M126.66M127.38M127.95M128.41M128.10M129.17M129.63M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
122.56M119.96M123.63M124.07M124.42M124.22M125.03M125.36M125.69M125.50M126.11M126.41M126.95M126.66M127.38M127.95M128.41M128.10M129.17M130.83M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
123.22M124.11M124.72M125.68M126.56M126.91M127.20M127.14M127.26M127.37M127.43M127.85M128.06M128.15M128.36M128.68M128.89M128.99M129.65M127.92M
EBITDA
-39.71M-41.57M-52.03M-39.70M-39.51M-26.38M-35.07M-29.89M-24.20M-18.57M-30.57M-21.94M-21.20M-18.40M-27.82M-47.63M-27.01M-13.41M-18.24M-9.77M
Interest ExpensesInt Expense
1.30M4.84M1.30M0.93M0.14M5.21M1.76M1.78M1.69M1.68M1.69M1.67M1.64M1.62M1.62M0.93M0.60M0.60M0.60M0.78M
Tax Rate
12.18%5.53%7.06%13.96%7.00%11.12%8.67%8.67%13.68%6.28%2.24%1.97%0.84%4.99%-1.04%1.58%-2.80%20.35%2.69%-22.56%